Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background The first compounds considered for stent-based delivery, such as heparin, were chosen on the basis of promising tissue culture and animal experiments, and yet they have failed to stop restenosis clinically. More recent compounds, such as paclitaxel, are of a different sort, being hydrophobic in nature, and their effects after local release seem far more profound. This dichotomy raises the question of whether drugs that have an effect when released from a stent do so because of differences in biology or differences in physicochemical properties and targeting. Methods and Results We applied continuum pharmacokinetics to examine the effects of transport forces and device geometry on the distribution of stent-delivered hydrophilic and hydrophobic drugs. We found that stent-based delivery invariably leads to large concentration gradients, with drug concentrations ranging from nil to several times the mean tissue concentration over a few micrometers. Concentration variations were a function of the Peclet number (Pe), the ratio of convective to diffusive forces. Although hydrophobic drugs exhibited greater variability than hydrophilic drugs, they achieved higher mean concentrations and remained closer to the intima. Inhomogeneous strut placement influenced hydrophilic drugs more negatively than hydrophobic drugs, dramatically affecting local concentrations without changing mean concentrations. Conclusions Because local concentrations and gradients are inextricably linked to biological effect, our results provide a potential explanation for the variable success of stent-based delivery. We conclude that mere proximity of delivery devices to tissues does not ensure adequate targeting, because physiological transport forces cause local concentrations to deviate significantly from mean concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roth, S., Stein, D., & Nüsslein-Volhard, C. (1989) · Cell · doi:10.1016/0092-8674(89)90774-5 · Cited by 652
Serruys, P. W., Emanuelsson, H., van der Giessen, W., Lunn, A. C., Kiemeney, F., Macaya, C., Rutsch, W., Heyndrickx, G., Suryapranata, H., Legrand, V., et al. (1996) · Circulation · doi:10.1161/01.cir.93.3.412 · Cited by 408
Tickle, C., Lee, J., & Eichele, G. (1985) · Developmental Biology · doi:10.1016/0012-1606(85)90348-3 · Cited by 308
Drachman, D. E., Edelman, E. R., Seifert, P., Groothuis, A. R., Bornstein, D. A., Kamath, K. R., Palasis, M., Yang, D., Nott, S. H., & Rogers, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01020-2 · Cited by 286
Self-citationLincoff, A. M., Furst, J. G., Ellis, S. G., Tuch, R. J., & Topol, E. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00584-0 · Cited by 282
Arterial Paclitaxel Distribution and Deposition
Creel, C. J., Lovich, M. A., & Edelman, E. R. (2000) · Circulation Research · doi:10.1161/01.res.86.8.879 · Cited by 279
Self-citationAllavena, P., Paganin, C., Zhou, D., Bianchi, G., Sozzani, S., & Mantovani, A. (1994) · Blood · doi:10.1182/blood.v84.7.2261.2261 · Cited by 101
Lambert, T., Dev, V., Rechavia, E., Forrester, J. S., Litvack, F., & Eigler, N. L. (1994) · Circulation · doi:10.1161/01.cir.90.2.1003 · Cited by 97
Alt, E., Haehnel, I., Beilharz, C., Prietzel, K., Preter, D., Stemberger, A., Fliedner, T., Erhardt, W., & Schömig, A. (2000) · Circulation · doi:10.1161/01.cir.101.12.1453 · Cited by 97
Preventive effects of the heparin-coated stent on restenosis in the porcine model
Ahn, Y. K., Jeong, M. H., Kim, J. W., Kim, S. H., Cho, J. H., Cho, J. G., Park, C. S., Juhng, S. W., Park, J. C., & Kang, J. C. (1999) · Catheterization and Cardiovascular Interventions · Cited by 75
Cited by
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Finn, A. V., Joner, M., Nakazawa, G., Kolodgie, F., Newell, J., John, M. C., Gold, H. K., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.107.693739 · Cited by 1,277
Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents
Joner, M., Nakazawa, G., Finn, A. V., Quee, S. C., Coleman, L., Acampado, E., Wilson, P. S., Skorija, K., Cheng, Q., Xu, X., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.030 · Cited by 641
Unverdorben, M., Vallbracht, C., Cremers, B., Heuer, H., Hengstenberg, C., Maikowski, C., Werner, G. S., Antoni, D., Kleber, F. X., Bocksch, W., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839282 · Cited by 511
Molecular Basis of Restenosis and Drug-Eluting Stents
Costa, M. A., & Simon, D. I. (2005) · Circulation · doi:10.1161/01.cir.0000163587.36485.a7 · Cited by 510
Mechanisms of controlled drug release from drug-eluting stents
Acharya, G., & Park, K. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.016 · Cited by 363
New Frontiers in Cardiology: Drug-Eluting Stents: Part I
Sousa, J. E., Serruys, P. W., & Costa, M. A. (2003) · Circulation · doi:10.1161/01.cir.0000069330.41022.90 · Cited by 349
Jefferson, K. K., Goldmann, D. A., & Pier, G. B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2467-2473.2005 · Cited by 319
“The relative roles of mixing and diffusion are represented in fluid dynamics by the Pe ´clet number (Pe), which is equal to the length of distance traveled (L) times the mixing or convection velocity (V), divided by the diffusion coefficient (D) and is represented as Pe LV/D ( 11 ).”
BackgroundMacroscale delivery systems for molecular and cellular payloads
Kearney, C. J., & Mooney, D. J. (2013) · Nature Materials · doi:10.1038/nmat3758 · Cited by 301
Drug-Eluting Stents in Preclinical Studies: Recommended Evaluation From a Consensus Group
Schwartz, R. S., Edelman, E. R., Carter, A., Chronos, N., Rogers, C., Robinson, K. A., Waksman, R., Weinberger, J., Wilensky, R. L., Jensen, D. N., et al. (2002) · Circulation · doi:10.1161/01.cir.0000033485.20594.6f · Cited by 291
Self-citationCurrent and Emerging Robot-Assisted Endovascular Catheterization Technologies: A Review
Rafii-Tari, H., Payne, C. J., & Yang, G.-Z. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0946-8 · Cited by 288
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.023 · Cited by 270
Drug-eluting stents: results, promises and problems
van der Hoeven, B. L., Pires, N. M. M., Warda, H. M., Oemrawsingh, P. V., van Vlijmen, B. J. M., Quax, P. H. A., Schalij, M. J., van der Wall, E. E., & Jukema, J. W. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.01.021 · Cited by 202
“Tissue levels depend on lipophilic or lipophobic characteristics, molecular weight and the degree of protein binding of the used drug.(21,22) Some drugs can be loaded directly onto the metallic surface of the stent, but most drugs need a polymer coating, which forms a reservoir for the drug.”
BackgroundThe Taxus™ drug-eluting stent: A new paradigm in controlled drug delivery
Kamath, K. R., Barry, J. J., & Miller, K. M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.023 · Cited by 174
Metadata
- Authors
- Hwang, C.-W., Wu, D., & Edelman, E. R.
- Venue
- Circulation
- Published
- 2001-07-31
- Volume
- 104
- Issue
- 5
- Pages
- 600-605
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2017919038
- Cited by
- 426
- References
- 12
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.